June 12th, 2025: EMA Links Semaglutide to Rare Vision Disorder The European Medicines Agency (EMA) has formally acknowledged a potential link between semaglutide, the key ingredient in Ozempic, Wegovy, and Rybelsus, and a rare but serious eye condition known as non-arteritic anterior ischemic optic neuropathy (NAION)
Summary A targeted and individualized nutrition and physical activity regimen should be instituted for each patient with a focus on optimizing protein intake and performing frequent resistance training in order to minimize loss of muscle mass while promoting the loss of fat mass
It effectively lowers A1c levels, an important indicator of long-term blood sugar control, and also helps manage postprandial and fasting blood glucose levels
It's a developing area, and staying updated on clinical trials.gov will be key
Beta-glucan fiber may help keep blood sugar balanced, lower blood pressure and help us pass on snacking between meals
Diagnostic features include symmetrical presentation, negative Stemmer's sign (ability to pinch skin at the base of the toes), and absence of pitting edema
